Myriad Genetics (MYGN)
(Real Time Quote from BATS)
$23.22 USD
+3.44 (17.39%)
Updated May 8, 2024 11:44 AM ET
4-Sell of 5 4
D Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | 0.00 |
EPS Last Quarter | -0.01 |
Last EPS Surprise | 90.91% |
ABR | 2.64 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.02 |
Next Year | 0.29 |
EPS (TTM) | -0.08 |
P/E (F1) | 814.47 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 205.52M | 210.85M | 827.67M | 894.83M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 209.39M | 213.26M | 831.20M | 909.50M |
Low Estimate | 203.81M | 209.36M | 824.35M | 885.84M |
Year ago Sales | 183.50M | 191.90M | 753.20M | 827.67M |
Year over Year Growth Est. | 12.00% | 9.87% | 9.89% | 8.11% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.00 | 0.03 | 0.02 | 0.29 |
# of Estimates | 5 | 5 | 7 | 7 |
Most Recent Consensus | -0.12 | 0.02 | 0.03 | 0.29 |
High Estimate | 0.02 | 0.06 | 0.04 | 0.37 |
Low Estimate | -0.01 | 0.01 | 0.02 | 0.20 |
Year ago EPS | -0.08 | -0.03 | -0.27 | 0.02 |
Year over Year Growth Est. | 100.00% | 200.00% | 107.41% | 1,335.72% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.00 | 0.03 | 0.02 | 0.29 |
7 Days Ago | 0.00 | 0.03 | 0.02 | 0.29 |
30 Days Ago | 0.00 | 0.03 | 0.02 | 0.30 |
60 Days Ago | 0.00 | 0.03 | 0.02 | 0.30 |
90 Days Ago | 0.01 | 0.00 | 0.02 | 0.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.00 | 0.03 | 0.02 | 0.29 |
Zacks Consensus Estimate | 0.00 | 0.03 | 0.02 | 0.29 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -0.49% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.01 | 0.04 | -0.03 | -0.08 | NA |
Estimate | -0.11 | 0.02 | -0.08 | -0.10 | NA |
Difference | 0.10 | 0.02 | 0.05 | 0.02 | 0.05 |
Surprise | 90.91% | 100.00% | 62.50% | 20.00% | 68.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more